Lung cancer is the most common cancer worldwide and the leading cause of cancer death in the US, with more patients dying each year than from breast, prostate, and colon cancers combined. But hope continues to build as new cases decrease steadily and mortality rates decline even faster, reflecting the success of ongoing public health campaigns, advances in early detection, and pioneering new treatments.
Spotlight on Lung Cancer takes an in-depth look at the driving forces and innovations behind these advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
Managing Immunotherapy Toxicities in Lung Cancer Patients
Exploring the Role of Biomarkers in Lung Cancer Treatment
Recognizing the Role of Capmatinib for METex14 in NSCLC
Checkpoint Inhibitor Combination Therapy for First-Line Advanced NSCLC
Serving the Underserved: The Role of CT Scans in Lung Cancer Screening
Exploring Advances in Treatment: A Step Forward in Small Cell Lung Cancer